While PPARγ has been implicated in lipid metabolism and adipocyte regulation, its role as a prognostic biomarker across breast cancer subtypes—particularly in relation to menopausal status and adipose metabolic activity—remains insufficiently understood. This evidence concerns the gene PPARG and breast cancer.